Candid Health

Automated revenue cycle management platform for healthcare

San Francisco, California, United States

About Candid Health

Candid Health specializes in automated revenue cycle management for healthcare providers. Its platform identifies and resolves issues that impact revenue cycles, helping to optimize insurance collections. The platform is designed to integrate seamlessly with various healthcare infrastructures, whether custom-built or commercial. Clients pay a subscription fee for access to the platform, which allows them to streamline their billing processes and improve revenue collection rates. Candid Health differentiates itself by focusing on automation and ease of integration, making it a reliable choice for healthcare providers seeking efficient billing solutions. The company's goal is to enhance the financial performance of healthcare providers by simplifying and improving their revenue cycle management.

San Francisco, CaliforniaHeadquarters
2019Year Founded
$43.9MTotal Funding
SERIES_BCompany Stage
Enterprise Software, HealthcareIndustries
51-200Employees

Benefits

Remote Work Options
Company Equity
Mental Health Support

Risks

Emerging startups in healthcare automation threaten Candid Health's market share.
Stricter compliance requirements could increase operational costs for Candid Health.
Continuous AI advancements may lead to increased R&D expenses for platform updates.

Differentiation

Candid Health automates revenue cycle management with AI, reducing administrative burdens for providers.
The platform offers seamless API integration, enhancing compatibility with existing healthcare systems.
Candid Health's end-to-end automation optimizes financial operations, improving patient experiences.

Upsides

AI-driven healthcare billing solutions are expected to grow by 40% in five years.
Blockchain integration offers enhanced security, complementing Candid Health's platform.
Telehealth's rise increases demand for efficient billing solutions, benefiting Candid Health.

Funding

Total raised$43.92 M
Latest valuation$145.00 M
StageSERIES_B
$29
$145.00 M
$16
$80.00 M
SEED
2/29/2020
N/A
$750.0 K